Is Parabellum funding the plaintiff in a case that is being billed as ‘Bitcoin’s Trial of the Century’?
Parabellum is funding a proposed Canadian class action against over 50 generic drug manufacturers. The proposed class action alleges that the defendants conspired to “allocate the market, fix prices and maintain the supply of generic drugs” contrary to the Competition Act, and claims damages of $2.75 billion.
Claudia Linares Arciniegas has joined Parabellum Capital in New York as Director of International Arbitration and Litigation. Claudia was previously with Tenor Capital Management.